PATENT CLAIM ANALYSIS

Application Number: 16169812
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["549", "054000"]

Abstract:
This invention is benzothiophene-based estrogen receptor downregulators and their compositions and uses to treat estrogen-related medical disorders.

Claim (Index 3):
The method of  claim 2 , wherein the estrogen-related disorder is a cancer.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 97.0
- Lexical Diversity: 1.05882
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15374966', '15764988', '15893295', '15531245', '13717326']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7618025749416222
- 35 USC 102 Novelty (BERT): 0.5914132294571879
- Combined Prediction Score: 0.7447636403931788
- Mean Citation Score: 427.842858
- Max Citation Score: 626.9444599999998
- Similarity Product: 380.1550257982693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test